Levine James E. 4
4 · Cidara Therapeutics, Inc. · Filed Mar 23, 2020
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Common Stock
2020-03-19+25,000→ 61,891 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-03-19+110,000→ 110,000 totalExercise: $1.98Exp: 2030-03-18→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]On December 3, 2018, the reporting person was granted a performance-based restricted stock unit (RSU) which would vest upon the achievement of various clinical and corporate milestones. On March 19, 2020 the Board accelerated the vesting of the RSU in full.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 19, 2020.